OOIR: Observatory of International Research

Papers

(The TQCC of Addiction Science & Clinical Practice is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review	61
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review	37
Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model	36
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis	33
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled tr	32
Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Netwo	31
PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment	31
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis	30
Multiple clinical risks for cannabis users during the COVID-19 pandemic	28
Racial/ethnic equity in substance use treatment research: the way forward	26
Substance use disorder bridge clinics: models, evidence, and future directions	26
Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis	23
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community	22
Adapting inpatient addiction medicine consult services during the COVID-19 pandemic	22
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities	20
The impact of project ECHO on physician preparedness to treat opioid use disorder: a systematic review	20
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review	19
External validation of an opioid misuse machine learning classifier in hospitalized adult patients	18
What do clinicians want? Understanding frontline addiction treatment clinicians’ preferences and priorities to improve the design of measurement-based care technology	18
Integrating traditional practices and social network visualization to prevent substance use: study protocol for a randomized controlled trial among urban Native American emerging adults	17
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and discontinuation strategie	17
Reimagining brief interventions for alcohol: towards a paradigm fit for the twenty first century?	17
‘Treat my whole person, not just my condition’: qualitative explorations of hepatitis C care delivery preferences among people who inject drugs	16
Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems	15
Clinicians’ perspectives and perceived barriers to caring for patients with alcohol use disorder and cirrhosis	15

“It’s way more than just writing a prescription”: A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder	14
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative	14
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder	14
Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study	13
Clinical leaders and providers’ perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs’ facilities	13
Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients	13
Prevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy	12
Should the CIWA-Ar be the standard monitoring strategy for alcohol withdrawal syndrome in the intensive care unit?	12
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes	12
“At least someone thinks I’m doing well”: a real-world evaluation of the quit-smoking app StopCoach for lower socio-economic status smokers	11
“It’s all about asking from those who have walked the path”: Patient and stakeholder perspectives on how peers may shift substance use stigma in HIV care in South Africa	11
Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County	11
Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites	11
The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting	11
Perceived family cohesion, social support, and quality of life in patients undergoing treatment for substance use disorders compared with patients with mental and physical disorders	10
Factors associated with patient-reported experiences and outcomes of substance use disorder treatment in Cape Town, South Africa	10
Information technology and addiction science: promises and challenges	10
Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown	10
Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care	10
Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study	10
Integrating a brief alcohol intervention with tobacco addiction treatment in primary care: qualitative study of health care practitioner perceptions	10
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation	9
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial	9
“Just fighting for my life to stay alive”: a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories	9
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule	9
Merging statewide data in a public/university collaboration to address opioid use disorder and overdose	8
Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature	8
A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the “peer tele-HCV” study	8
Financial sustainability of payment models for office-based opioid treatment in outpatient clinics	8
Expanding access to medications for opioid use disorder through locally-initiated implementation	8
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates	8
Addressing complex pharmacy consultations: methods used to develop a person-centred intervention to highlight alcohol within pharmacist reviews of medications	8
Housing, opportunities, motivation and engagement (HOME) for homeless youth at-risk for opioid use disorder: study protocol for a randomized controlled trial	8
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders	8
Patient outcomes and experience of a task-shared screening and brief intervention service for problem substance use in South African emergency centres: a mixed methods study	7
Feasibility and acceptability of electronic administration of patient reported outcomes using mHealth platform in emergency department patients with non-medical opioid use	7
Physician blame and vulnerability: novel predictors of physician willingness to work with patients who misuse opioids	7
Electronic cigarettes’ withdrawal severity symptoms among users during intermittent fasting: a cross-sectional study	7
Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-fe	7
Improving Treatment Together: a protocol for a multi-phase, community-based participatory, and co-design project to improve youth opioid treatment service experiences in British Columbia	6
Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study	6
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs	6
A novel brief treatment for methamphetamine use disorders in South Africa: a randomised feasibility trial	6
Optimizing internet-delivered cognitive behaviour therapy for alcohol misuse—a randomized factorial trial examining effects of a pre-treatment assessment interview and guidance	6
Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial	6
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis	6
Risk of COVID-19 infection and the associated hospitalization, ICU admission and mortality in opioid use disorder: a systematic review and meta-analysis	6
Alcohol consumption and dependence is linked to the extent that people experience need satisfaction while drinking alcohol in two Aboriginal and Torres Strait Islander communities	6
HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England	6